EUVIMEDEUVIMED entdecken
Crossref

Patency and survival analysis of hemodialysis arteriovenous fistula and influencing factors of fistula dysfunction

Jianwei Liu iD, Yu Zhang, Qingnan Xie, Shaowen Hu

The Journal of Vascular Access · 2026

DOI: 10.1177/11297298261443398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Vascular Access, 2026. Verfasst von Jianwei Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Urology Department, Beijing You An Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Renal Dialysis, Vascular Patency, Graft Occlusion, Vascular. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Establishing reliable vascular access is vital for end-stage renal disease (ESRD) patients. This study evaluated autogenous arteriovenous fistula (AVF) patency rates and identified independent factors associated with dysfunction to optimize postoperative management.

Methods

We retrospectively analyzed 186 patients undergoing their first AVF creation between 2021 and 2023, with follow-up through July 20, 2025. Statistical methods included multivariate Cox regression (treating Hb and TG as continuous variables), restricted cubic spline (RCS) analysis for non-linear trends, and Fine-Gray competing risk models to differentiate dysfunction subtypes.

Results

The primary patency rates at 6, 12, and 24 months were 85.48%, 79.57%, and 76.34%, respectively. During follow-up, 28.0% (52/186) of patients experienced dysfunction, primarily due to thrombosis (46.2%) and stenosis (34.6%). Multivariate Cox analysis identified relatively higher baseline Hb (HR = 1.017 per 1 g/L increase, 95% CI: 1.001–1.033, p = 0.033) and TG (HR = 1.850 per 1 mmol/L increase, 95% CI: 1.048–3.265, p = 0.034) as independent risk factors. Conversely, larger preoperative vessel diameters and senior surgeon experience served as significant protective factors ( p < 0.05). RCS analysis confirmed a near-linear increase in dysfunction risk as Hb levels rose within the ESRD-prevalent range ( p for non-linearity = 0.412). ROC analysis yielded AUCs of 0.718 for Hb (cut-off >101.5 g/L) and 0.677 for TG (cut-off >1.915 mmol/L).

Conclusion

Relatively higher baseline Hb and TG levels are independently associated with increased AVF dysfunction risk, alongside anatomical and technical determinants. Individualized metabolic monitoring and optimized surgical selection are recommended to enhance fistula longevity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arteriovenous Shunt, SurgicalRenal DialysisVascular PatencyGraft Occlusion, VascularKidney Failure, ChronicHumansRisk FactorsFemaleRetrospective StudiesMaleTime FactorsMiddle AgedAgedRisk AssessmentTreatment OutcomeBiomarkersHemoglobinsThrombosisAdult

Stichwörter der Autor:innen

Arteriovenous fistuladysfunctionhemoglobinpatency raterisk factorstriglycerides

Substanzen

BiomarkersHemoglobins

Autor:innen und Institutionen

  • Urology Department, Beijing You An Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Jianwei Liu

Zitieren

APA

Liu, J., Zhang, Y., Xie, Q., & Hu, S. (2026). Patency and survival analysis of hemodialysis arteriovenous fistula and influencing factors of fistula dysfunction. The Journal of Vascular Access. https://doi.org/10.1177/11297298261443398

Vancouver

Liu J, Zhang Y, Xie Q, Hu S. Patency and survival analysis of hemodialysis arteriovenous fistula and influencing factors of fistula dysfunction. The Journal of Vascular Access. 2026. doi:10.1177/11297298261443398

BibTeX
@article{Liu2026,
  author = {Liu, Jianwei and Zhang, Yu and Xie, Qingnan and Hu, Shaowen},
  title = {Patency and survival analysis of hemodialysis arteriovenous fistula and influencing factors of fistula dysfunction},
  journal = {The Journal of Vascular Access},
  year = {2026},
  doi = {10.1177/11297298261443398}
}
Kostenlos starten →